Gaps in guideline-recommended anticoagulation in patients with atrial fibrillation and elevated thromboembolic risk within an integrated healthcare delivery system

BACKGROUND: Atrial Fibrillation (AF) is the leading cause of stroke, which can be reduced by 70% with appropriate oral anticoagulation (OAC) therapy. Nationally, appropriate anticoagulation rates for patients with AF with elevated thromboembolic risk are as low as 50% even across the highest stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Sushmita, Gustafson, Shanshan, Chang, Huai-En R., Tamrat, Yonas, Go, Alan S., Berry, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664365/
https://www.ncbi.nlm.nih.gov/pubmed/37990153
http://dx.doi.org/10.1186/s12872-023-03607-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664365/
https://www.ncbi.nlm.nih.gov/pubmed/37990153
http://dx.doi.org/10.1186/s12872-023-03607-y

Ejemplares similares